Medincell SA banner

Intrinsic Value

Is MEDCL undervalued or overvalued?

See the intrinsic value estimate for Medincell SA and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

MEDCL Intrinsic Value
LOCKED
Unlock
Today vs. history

MEDCL looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with MEDCL’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor MEDCL
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price €25.44
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to MEDCL

Fundamental Analysis

What Medincell Does

Pharmaceuticals Health Care

Medincell SA is a French drug development company that makes long-acting injectable medicines. It uses a formulation technology that turns existing or new drugs into shots that release medicine slowly over days, weeks, or months. The goal is to make treatment easier to follow for patients who need regular medicine but may struggle with daily pills or frequent injections.

Headquarters
France FR
Employees
145
IPO date
Oct 8, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Medincell SA

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one MEDCL stock?

The intrinsic value for Medincell SA (MEDCL) under the Base Case is hidden EUR.

Is MEDCL stock undervalued or overvalued?

Compared with the current market price of 25.44 EUR, the stock appears hidden.

Back to Top